KRAS and cancer: While compounds like erastin effectively induce ferroptosis through pharmacological inhibition of SLC7A11,28 another investigation demonstrated that HG106, an efficient inhibitor of SLC7A11, induced apoptosis rather than ferroptosis in KRAS‐mutant cancer cells by inhibiting cystine uptake and intracellular GSH biosynthesis.34